The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(i)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(2)(ii)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Subparagraph (e)(1)
-Name Accounting Standards Codification
-Paragraph 2
-Section 50
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20210218Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20220314Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20230504Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20240301Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20240401Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_AwardDateAxis=tpb_AwardsGranted20250303Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Note 13 - Share Incentive Plans - Summary of Performance Shares (Details) - Performance Shares [Member] - $ / shares							3 Months Ended
	Mar. 03, 2025	Apr. 01, 2024	Mar. 01, 2024	May 04, 2023	Mar. 14, 2022	Feb. 18, 2021	Mar. 31, 2025
Equity instruments outstanding (in shares)							286,655
Awards Granted 20210218 [Member]
Number of instruments granted (in shares)						100,000
Equity instruments outstanding (in shares)							69,190
Fair value as of grant date (in dollars per share)							$ 51.75
Remaining lives (Year)							9 months
Awards Granted 20220314 [Member]
Number of instruments granted (in shares)					49,996
Equity instruments outstanding (in shares)							21,745
Fair value as of grant date (in dollars per share)							$ 30.46
Remaining lives (Year)							1 year 9 months
Awards Granted 20230504 [Member]
Number of instruments granted (in shares)				133,578
Equity instruments outstanding (in shares)							69,972
Fair value as of grant date (in dollars per share)							$ 22.25
Remaining lives (Year)							9 months
Awards Granted 20240301 [Member]
Number of instruments granted (in shares)			111,321
Equity instruments outstanding (in shares)							78,017
Fair value as of grant date (in dollars per share)							$ 26.52
Remaining lives (Year)							1 year 9 months
Awards Granted 20240401 [Member]
Number of instruments granted (in shares)		8,242
Equity instruments outstanding (in shares)							6,594
Fair value as of grant date (in dollars per share)							$ 29.12
Remaining lives (Year)							1 year 9 months
Awards Granted 20250303 [Member]
Number of instruments granted (in shares)	41,137
Equity instruments outstanding (in shares)							41,137
Fair value as of grant date (in dollars per share)							$ 70.34
Remaining lives (Year)							2 years 9 months